Recovery & Performance

Tesamorelin

Growth Hormone-Releasing Hormone Analog

Tesamorelin is the peptide inside two of our most requested protocols — Sculpt Ascent and Power Triad — and it is one of the more thoroughly studied compounds in the growth hormone category. It is a GHRH analog, meaning it signals the pituitary to release growth hormone on the body’s own schedule rather than introducing hormone directly. What separates it from other GHRH peptides is its documented relationship with visceral adipose tissue: the deep abdominal fat stored around the organs, which behaves differently from the subcutaneous fat you can pinch. For patients who want that mechanism on its own rather than inside a blend, Tesamorelin is now available as a standalone protocol.

Benefits

Supports growth hormone release with a particular association to visceral fat metabolism and body composition.

Signals the pituitary to release growth hormone in natural pulses
Specific mechanistic association with visceral adipose tissue
Supports body composition, recovery, and sleep quality
Available standalone or stacked inside Sculpt Ascent and Power Triad
One of the most studied compounds in the GHRH category

Safety Information

Avoid during pregnancy, while breastfeeding, or with active cancer. Mild fluid retention, joint discomfort, or injection site reaction may occur. Because elevated growth hormone can affect insulin sensitivity, individuals with diabetes or impaired glucose tolerance should be monitored by their provider throughout the protocol. Always consult your provider before starting.

Regimen

6 or 12 weeks of injections Monday through Friday in the afternoon or evening. Dosing guide: 5 days on, 2 days off.

How to Take

Subcutaneous injection near the lower abdomen or outer thigh. Use sterile technique. Rotate injection sites.

How It Works

Tesamorelin is a stabilized analog of growth hormone-releasing hormone. It binds GHRH receptors on the anterior pituitary, prompting release of the body’s own growth hormone in a pulsatile pattern that mirrors natural physiology. Downstream, growth hormone drives IGF-1 production and increases lipolysis — the breakdown of stored fat. Visceral adipose tissue is more metabolically active and more responsive to growth hormone signaling than subcutaneous fat, which is why this mechanism is associated specifically with the abdominal compartment rather than with weight generally.

Tesamorelin is the most clinically studied GHRH analog available. It has been evaluated in multiple randomized, placebo-controlled trials, and an FDA-approved formulation exists for a specific medical indication involving excess abdominal fat. Those trials are where its association with visceral adipose tissue comes from: imaging studies showed reductions in the visceral compartment specifically, with IGF-1 levels rising as expected from growth hormone stimulation. The same research is the source of the monitoring recommendation for patients with impaired glucose tolerance, since growth hormone can affect insulin sensitivity. What the trials do not establish is an effect in every population or at every dose — the studied population was specific, and results in general wellness use are extrapolated from that mechanism. Compounded tesamorelin is not an FDA-approved product; it is prepared for individual patients under prescription.

FAQs

What is tesamorelin?

A stabilized analog of growth hormone-releasing hormone. It binds GHRH receptors on the pituitary and prompts release of your own growth hormone in natural pulses. It is one of the most studied peptides in its class.

How is tesamorelin different from sermorelin?

Both are GHRH analogs. Tesamorelin has a modified structure that resists breakdown, giving it more sustained activity, and it carries the most specific research record on visceral fat of any GHRH peptide. Sermorelin is generally the gentler, more gradual option.

Is tesamorelin the same as taking growth hormone?

No. It signals the pituitary to release the growth hormone your body already makes, in the pulsatile pattern the body uses natively. Direct growth hormone bypasses that regulation entirely.

How is tesamorelin dosed?

Monday through Friday in the afternoon or evening, 5 days on and 2 days off, for 6 or 12 weeks. Subcutaneous injection near the lower abdomen or outer thigh.

Can I take tesamorelin with other peptides?

Yes. It pairs with Ipamorelin in Sculpt Ascent and with Ipamorelin and MGF in Power Triad, because Ipamorelin works through a different receptor and the effects are additive. Your provider will recommend standalone or blend based on your goals.

How to Use Your Peptides

Before you get started with your peptide protocol, we recommend reviewing our Injection Guide to ensure safe and effective use. This quick-reference document walks you through proper subcutaneous injection technique, storage tips, and other best practices.

Each protocol below includes recommended timing, injection instructions, safety notes, and how the peptides work in your body. As always, please follow your provider’s guidance, and please reach out with any questions!